Key result
Primary stroke prevention trials in older adults face design challenges due to higher coronary disease rates.
Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: Prevention of a first stroke is an important strategy to reduce morbidity and mortality associated with cerebrovascular disease. In this discussion, we review challenges to development of clinical trials for prevention of a first stroke. Summary of Review- We discuss prevention of first stroke in the context of clinical trial design in the ARRIVE trial and a primary prevention trial in development for the elderly. CONCLUSIONS: Stroke is an important outcome in cerebrovascular disease trials in the elderly, but it may be trumped by coronary heart disease as a more common end point.
No takes yet. Share an insight, caveat, or question.
Philip B. Gorelick (2008) conducted a review in Primary prevention of stroke / Cerebrovascular disease. Primary stroke prevention trials in the elderly face design challenges because coronary heart disease is a more common endpoint than stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: